106 related articles for article (PubMed ID: 22520053)
1. Distant metastases from head and neck squamous cell carcinoma. Part II. Diagnosis.
de Bree R; Haigentz M; Silver CE; Paccagnella D; Hamoir M; Hartl DM; Machiels JP; Paleri V; Rinaldo A; Shaha AR; Takes RP; Leemans CR; Ferlito A
Oral Oncol; 2012 Sep; 48(9):780-6. PubMed ID: 22520053
[TBL] [Abstract][Full Text] [Related]
2. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
[TBL] [Abstract][Full Text] [Related]
3. Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial.
Senft A; de Bree R; Hoekstra OS; Kuik DJ; Golding RP; Oyen WJ; Pruim J; van den Hoogen FJ; Roodenburg JL; Leemans CR
Radiother Oncol; 2008 May; 87(2):221-9. PubMed ID: 18410977
[TBL] [Abstract][Full Text] [Related]
4. Screening for distant metastases in patients with head and neck cancer: is chest computed tomography sufficient?
Brouwer J; de Bree R; Hoekstra OS; Golding RP; Langendijk JA; Castelijns JA; Leemans CR
Laryngoscope; 2005 Oct; 115(10):1813-7. PubMed ID: 16222201
[TBL] [Abstract][Full Text] [Related]
5. Screening for distant metastases in patients with head and neck cancer: what is the current clinical practice?
Brouwer J; Bree R; Hoekstra OS; Langendijk JA; Castelijns JA; Leemans CR
Clin Otolaryngol; 2005 Oct; 30(5):438-43. PubMed ID: 16232248
[TBL] [Abstract][Full Text] [Related]
6. 18FDG SUV in the primary tumor and lymph node metastases is not predictive for development of distant metastases in high risk head and neck cancer patients.
Meeuwis J; Hoekstra OS; Witte BI; Boellaard R; Leemans CR; de Bree R
Oral Oncol; 2015 May; 51(5):536-40. PubMed ID: 25735655
[TBL] [Abstract][Full Text] [Related]
7. Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients.
Uyl-de Groot CA; Senft A; de Bree R; Leemans CR; Hoekstra OS
J Nucl Med; 2010 Feb; 51(2):176-82. PubMed ID: 20124045
[TBL] [Abstract][Full Text] [Related]
8. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
9. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
Basu D; Siegel BA; McDonald DJ; Nussenbaum B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.
Krabbe CA; Pruim J; van der Laan BF; Rödiger LA; Roodenburg JL
Oral Oncol; 2009 Mar; 45(3):234-40. PubMed ID: 18715818
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment screening on distant metastases and head and neck cancer patients: Validation of risk factors and influence on survival.
Peters TT; Senft A; Hoekstra OS; Castelijns JA; Witte BI; Leemans CR; de Bree R
Oral Oncol; 2015 Mar; 51(3):267-71. PubMed ID: 25552384
[TBL] [Abstract][Full Text] [Related]
12. Interobserver variability in chest CT and whole body FDG-PET screening for distant metastases in head and neck cancer patients.
Senft A; de Bree R; Golding RP; Comans EF; Van Waesberghe JH; Kuik JD; Hoekstra OS; Leemans CR
Mol Imaging Biol; 2011 Apr; 13(2):385-90. PubMed ID: 20533092
[TBL] [Abstract][Full Text] [Related]
13. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.
Kim SY; Kim JS; Yi JS; Lee JH; Choi SH; Nam SY; Cho KJ; Lee SW; Kim SB; Roh JL
Ann Surg Oncol; 2011 Sep; 18(9):2579-84. PubMed ID: 21409485
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment screening for distant metastases in the Dutch head and neck centers: 10 years later.
Senft A; Hoekstra OS; Castelijns JA; Leemans CR; de Bree R
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3287-91. PubMed ID: 26769038
[TBL] [Abstract][Full Text] [Related]
16. Screening for distant metastases in patients with head and neck cancer.
de Bree R; Deurloo EE; Snow GB; Leemans CR
Laryngoscope; 2000 Mar; 110(3 Pt 1):397-401. PubMed ID: 10718426
[TBL] [Abstract][Full Text] [Related]
17. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
[TBL] [Abstract][Full Text] [Related]
18. Staging of head and neck squamous cell cancer with extended-field FDG-PET.
Schwartz DL; Rajendran J; Yueh B; Coltrera M; Anzai Y; Krohn K; Eary J
Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1173-8. PubMed ID: 14623746
[TBL] [Abstract][Full Text] [Related]
19. Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET?
Brouwer J; Senft A; de Bree R; Comans EF; Golding RP; Castelijns JA; Hoekstra OS; Leemans CR
Oral Oncol; 2006 Mar; 42(3):275-80. PubMed ID: 16266820
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography-computed tomography: a superior and one-stop shop modality for treated head and neck carcinoma compared with conventional tomography.
Ichpujani VK; Rao SA; Chaturvedi AK; Dewan AK; Choudhary PS
J Oral Maxillofac Surg; 2014 Nov; 72(11):2319-32. PubMed ID: 25438279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
